Efficacy of Plate Expression of Meibum on Tear Function and Ocular Surface Findings in Meibomian Gland Disease

Naohiko Aketa, Megumi Shinzawa, Motoko Kawashima, Murat Dogru, Shosei Okamoto, Kazuo Tsubota, Jun Shimazaki

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

PURPOSE: To evaluate the clinical effectiveness of expression treatment on meibomian gland disease (MGD). METHODS: Seventeen right eyes of 17 patients with MGD were divided into 3 groups in this randomized prospective clinical study: no expression group: routine treatment with no expression (five patients, five eyes); digital expression group: routine treatment with digital expression (five patients, five eyes); and plate expression group: routine treatment with plate expression (seven patients, seven eyes). All groups received the same routine treatment for 1 month. Tear film break-up time (TBUT), vital staining scores, meibum expressibility, and the dry eye-related quality of life score (DEQS) questionnaire results were assessed before and 1 month after treatment. RESULTS: There was a statistically significant difference of posttreatment TBUT among groups as determined by one-way analysis of variance (P<0.05). A post hoc test revealed that TBUT was statistically significantly higher in plate expression group compared with digital expression group. The fluorescein staining score did not show a statistically significant difference among the groups. Meibum expressibility and the DEQS scores improved in all groups. CONCLUSION: Plate expression when used as an adjunct to routine medical management of MGD has been found to be a comparatively effective treatment in terms of improvement of tear film stability compared with no expression or digital expression.

Original languageEnglish
Pages (from-to)19-22
Number of pages4
JournalEye & contact lens
Volume45
Issue number1
DOIs
Publication statusPublished - 2019 Jan 1

Fingerprint

Meibomian Glands
Tears
Therapeutics
Quality of Life
Staining and Labeling
Fluorescein
Analysis of Variance
Prospective Studies

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Efficacy of Plate Expression of Meibum on Tear Function and Ocular Surface Findings in Meibomian Gland Disease. / Aketa, Naohiko; Shinzawa, Megumi; Kawashima, Motoko; Dogru, Murat; Okamoto, Shosei; Tsubota, Kazuo; Shimazaki, Jun.

In: Eye & contact lens, Vol. 45, No. 1, 01.01.2019, p. 19-22.

Research output: Contribution to journalArticle

Aketa, Naohiko ; Shinzawa, Megumi ; Kawashima, Motoko ; Dogru, Murat ; Okamoto, Shosei ; Tsubota, Kazuo ; Shimazaki, Jun. / Efficacy of Plate Expression of Meibum on Tear Function and Ocular Surface Findings in Meibomian Gland Disease. In: Eye & contact lens. 2019 ; Vol. 45, No. 1. pp. 19-22.
@article{d91021353c6f43d68199d1c3653ccda4,
title = "Efficacy of Plate Expression of Meibum on Tear Function and Ocular Surface Findings in Meibomian Gland Disease",
abstract = "PURPOSE: To evaluate the clinical effectiveness of expression treatment on meibomian gland disease (MGD). METHODS: Seventeen right eyes of 17 patients with MGD were divided into 3 groups in this randomized prospective clinical study: no expression group: routine treatment with no expression (five patients, five eyes); digital expression group: routine treatment with digital expression (five patients, five eyes); and plate expression group: routine treatment with plate expression (seven patients, seven eyes). All groups received the same routine treatment for 1 month. Tear film break-up time (TBUT), vital staining scores, meibum expressibility, and the dry eye-related quality of life score (DEQS) questionnaire results were assessed before and 1 month after treatment. RESULTS: There was a statistically significant difference of posttreatment TBUT among groups as determined by one-way analysis of variance (P<0.05). A post hoc test revealed that TBUT was statistically significantly higher in plate expression group compared with digital expression group. The fluorescein staining score did not show a statistically significant difference among the groups. Meibum expressibility and the DEQS scores improved in all groups. CONCLUSION: Plate expression when used as an adjunct to routine medical management of MGD has been found to be a comparatively effective treatment in terms of improvement of tear film stability compared with no expression or digital expression.",
author = "Naohiko Aketa and Megumi Shinzawa and Motoko Kawashima and Murat Dogru and Shosei Okamoto and Kazuo Tsubota and Jun Shimazaki",
year = "2019",
month = "1",
day = "1",
doi = "10.1097/ICL.0000000000000535",
language = "English",
volume = "45",
pages = "19--22",
journal = "Eye and Contact Lense",
issn = "1542-2321",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Efficacy of Plate Expression of Meibum on Tear Function and Ocular Surface Findings in Meibomian Gland Disease

AU - Aketa, Naohiko

AU - Shinzawa, Megumi

AU - Kawashima, Motoko

AU - Dogru, Murat

AU - Okamoto, Shosei

AU - Tsubota, Kazuo

AU - Shimazaki, Jun

PY - 2019/1/1

Y1 - 2019/1/1

N2 - PURPOSE: To evaluate the clinical effectiveness of expression treatment on meibomian gland disease (MGD). METHODS: Seventeen right eyes of 17 patients with MGD were divided into 3 groups in this randomized prospective clinical study: no expression group: routine treatment with no expression (five patients, five eyes); digital expression group: routine treatment with digital expression (five patients, five eyes); and plate expression group: routine treatment with plate expression (seven patients, seven eyes). All groups received the same routine treatment for 1 month. Tear film break-up time (TBUT), vital staining scores, meibum expressibility, and the dry eye-related quality of life score (DEQS) questionnaire results were assessed before and 1 month after treatment. RESULTS: There was a statistically significant difference of posttreatment TBUT among groups as determined by one-way analysis of variance (P<0.05). A post hoc test revealed that TBUT was statistically significantly higher in plate expression group compared with digital expression group. The fluorescein staining score did not show a statistically significant difference among the groups. Meibum expressibility and the DEQS scores improved in all groups. CONCLUSION: Plate expression when used as an adjunct to routine medical management of MGD has been found to be a comparatively effective treatment in terms of improvement of tear film stability compared with no expression or digital expression.

AB - PURPOSE: To evaluate the clinical effectiveness of expression treatment on meibomian gland disease (MGD). METHODS: Seventeen right eyes of 17 patients with MGD were divided into 3 groups in this randomized prospective clinical study: no expression group: routine treatment with no expression (five patients, five eyes); digital expression group: routine treatment with digital expression (five patients, five eyes); and plate expression group: routine treatment with plate expression (seven patients, seven eyes). All groups received the same routine treatment for 1 month. Tear film break-up time (TBUT), vital staining scores, meibum expressibility, and the dry eye-related quality of life score (DEQS) questionnaire results were assessed before and 1 month after treatment. RESULTS: There was a statistically significant difference of posttreatment TBUT among groups as determined by one-way analysis of variance (P<0.05). A post hoc test revealed that TBUT was statistically significantly higher in plate expression group compared with digital expression group. The fluorescein staining score did not show a statistically significant difference among the groups. Meibum expressibility and the DEQS scores improved in all groups. CONCLUSION: Plate expression when used as an adjunct to routine medical management of MGD has been found to be a comparatively effective treatment in terms of improvement of tear film stability compared with no expression or digital expression.

UR - http://www.scopus.com/inward/record.url?scp=85058878938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058878938&partnerID=8YFLogxK

U2 - 10.1097/ICL.0000000000000535

DO - 10.1097/ICL.0000000000000535

M3 - Article

VL - 45

SP - 19

EP - 22

JO - Eye and Contact Lense

JF - Eye and Contact Lense

SN - 1542-2321

IS - 1

ER -